Burney Company’s Eli Lilly LLY Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$29.3M Sell
24,397
-361
-1% -$369K 0.79% 17
2026
Q1
$22.8M Sell
24,758
-3,302
-12% -$3.35M 0.71% 22
2025
Q4
$30.2M Sell
28,060
-9
-0% -$8.61K 0.94% 17
2025
Q3
$21.4M Sell
28,069
-546
-2% -$406K 0.68% 32
2025
Q2
$22.3M Sell
28,615
-1,533
-5% -$1.19M 0.76% 32
2025
Q1
$24.9M Sell
30,148
-1,547
-5% -$1.29M 0.91% 24
2024
Q4
$24.5M Sell
31,695
-1,375
-4% -$1.14M 0.86% 22
2024
Q3
$29.3M Sell
33,070
-1,395
-4% -$1.25M 1.04% 16
2024
Q2
$31.2M Sell
34,465
-2,151
-6% -$1.72M 1.19% 11
2024
Q1
$28.5M Sell
36,616
-518
-1% -$369K 1.09% 16
2023
Q4
$21.6M Sell
37,134
-657
-2% -$383K 0.91% 17
2023
Q3
$20.3M Sell
37,791
-616
-2% -$317K 0.95% 14
2023
Q2
$18M Sell
38,407
-810
-2% -$340K 0.83% 16
2023
Q1
$13.5M Sell
39,217
-1,791
-4% -$604K 0.66% 26
2022
Q4
$15M Sell
41,008
-4,510
-10% -$1.6M 0.76% 25
2022
Q3
$14.7M Sell
45,518
-2,643
-5% -$837K 0.81% 22
2022
Q2
$15.6M Sell
48,161
-1,469
-3% -$441K 0.82% 21
2022
Q1
$14.2M Sell
49,630
-137
-0.3% -$35.3K 0.65% 31
2021
Q4
$13.7M Sell
49,767
-321
-0.6% -$81.4K 0.59% 43
2021
Q3
$11.6M Sell
50,088
-533
-1% -$132K 0.54% 51
2021
Q2
$11.6M Sell
50,621
-10,271
-17% -$2.06M 0.54% 48
2021
Q1
$11.4M Sell
60,892
-5,539
-8% -$1.08M 0.56% 49
2020
Q4
$11.2M Sell
66,431
-3,909
-6% -$584K 0.62% 38
2020
Q3
$10.4M Sell
70,340
-2,894
-4% -$448K 0.65% 36
2020
Q2
$12M Sell
73,234
-28,589
-28% -$4.39M 0.78% 27
2020
Q1
$14.1M Sell
101,823
-6,064
-6% -$833K 1.09% 16
2019
Q4
$14.2M Buy
107,887
+853
+0.8% +$98.9K 0.78% 24
2019
Q3
$12M Sell
107,034
-5,728
-5% -$638K 0.72% 32
2019
Q2
$12.5M Sell
112,762
-6,246
-5% -$736K 0.76% 28
2019
Q1
$15.4M Sell
119,008
-4,196
-3% -$510K 0.96% 19
2018
Q4
$14.3M Buy
123,204
+2,260
+2% +$252K 1% 18
2018
Q3
$13M Sell
120,944
-22,496
-16% -$2.25M 0.77% 31
2018
Q2
$12.2M Buy
143,440
+19,175
+15% +$1.57M 0.72% 35
2018
Q1
$9.61M Sell
124,265
-24,074
-16% -$1.94M 0.6% 51
2017
Q4
$12.5M Buy
148,339
+14,565
+11% +$1.24M 0.71% 39
2017
Q3
$11.4M Sell
133,774
-2,486
-2% -$204K 0.74% 40
2017
Q2
$11.3M Sell
136,260
-4,726
-3% -$386K 0.74% 45
2017
Q1
$11.9M Sell
140,986
-238
-0.2% -$19.1K 0.78% 41
2016
Q4
$10.4M Sell
141,224
-3,084
-2% -$230K 0.71% 46
2016
Q3
$11.6M Buy
144,308
+1,254
+0.9% +$100K 0.82% 37
2016
Q2
$11.3M Sell
143,054
-2,496
-2% -$188K 0.81% 38
2016
Q1
$10.5M Sell
145,550
-6,470
-4% -$490K 0.76% 40
2015
Q4
$13M Buy
152,020
+223
+0.1% +$18.5K 0.96% 31
2015
Q3
$12.7M Sell
151,797
-6,031
-4% -$509K 0.98% 28
2015
Q2
$13.2M Buy
157,828
+1,300
+0.8% +$99.1K 0.9% 32
2015
Q1
$11.4M Buy
156,528
+15,070
+11% +$1.07M 0.78% 40
2014
Q4
$9.76M Buy
141,458
+765
+0.5% +$51.6K 0.77% 45
2014
Q3
$9.12M Buy
140,693
+11,874
+9% +$752K 0.78% 40
2014
Q2
$8.01M Buy
128,819
+6,804
+6% +$406K 0.69% 49
2014
Q1
$7.18M Buy
122,015
+1,050
+0.9% +$58.6K 0.65% 51
2013
Q4
$6.17M Sell
120,965
-14,810
-11% -$742K 0.6% 56
2013
Q3
$6.83M Buy
135,775
+2,232
+2% +$117K 0.76% 40
2013
Q2
$6.56M Buy
+133,543
New +$7.27M 0.82% 35

Other funds holding LLY

Burney Company's LLY Position: Q2 2026 in Review

Burney Company reduced its Eli Lilly (LLY) stake by 1.5% in Q2 2026, selling an estimated $369K and leaving 24,397 shares worth $29.3M. The position accounts for 0.79% of the portfolio, ranked #17.

Burney Company first reported a position in LLY in Q2 2013 and has held it in 53 quarters since. The position peaked at $31.2M in Q2 2024. 841 funds tracked by Wall St. Rank hold LLY as of Q2 2026.

  • Burney Company held 24,397 shares of Eli Lilly worth $29.3M as of Q2 2026.
  • Burney Company sold 361 Eli Lilly shares in Q2 2026, an estimated $369K.
  • Eli Lilly made up 0.79% of Burney Company's portfolio in Q2 2026, its #17 holding.
  • Burney Company first reported a position in Eli Lilly in Q2 2013 and has held it in 53 quarters since.
  • Burney Company's Eli Lilly position peaked at $31.2M in Q2 2024.
  • 841 funds tracked by Wall St. Rank held Eli Lilly as of Q2 2026.

Based on Burney Company's 13F filing for Q2 2026, filed 15 Jul 2026.